Long-Term Outcomes, Secondary Malignancies, and Stem Cell Collection Following Bendamustine in Patients with Previously Treated Indolent Non-Hodgkin LymphomaPeter Martin, John P. Leonard, Bruce D. Cheson et al.|Blood|2015Cited by 0